OTCPK:GMMV.F

Stock Analysis Report

G Medical Innovations Holdings

Executive Summary

G Medical Innovations Holdings Ltd operates as a mobile health and e-health company.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Share Price & News

How has G Medical Innovations Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

GMMV.F

1.4%

US Healthcare Services

1.8%

US Market


1 Year Return

n/a

GMMV.F

15.6%

US Healthcare Services

7.3%

US Market


Shareholder returns

GMMV.FIndustryMarket
7 Day0%1.4%1.8%
30 Day0%-0.9%-0.7%
90 Day0%-5.3%0.06%
1 Yearn/a15.8%15.6%9.7%7.3%
3 Yearn/a57.1%56.6%46.3%36.9%
5 Yearn/a49.8%48.7%64.5%46.5%

Price Volatility Vs. Market

How volatile is G Medical Innovations Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is G Medical Innovations Holdings undervalued compared to its fair value and its price relative to the market?


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate GMMV.F's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate GMMV.F's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: GMMV.F is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.

PE vs Market: GMMV.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate GMMV.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GMMV.F has negative assets, so we can't compare its PB Ratio to the US Healthcare Services industry average.


Next Steps

Future Growth

How is G Medical Innovations Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.7%

Forecasted Healthcare industry annual growth in earnings


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if GMMV.F's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if GMMV.F's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if GMMV.F's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if GMMV.F's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has G Medical Innovations Holdings performed over the past 5 years?

-25.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: GMMV.F is unprofitable, and losses have increased over the past 5 years at a rate of -25.8% per year.

Accelerating Growth: Unable to compare GMMV.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GMMV.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.3%).


Return on Equity

High ROE: GMMV.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets

ROA vs Industry: GMMV.F is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: GMMV.F is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is G Medical Innovations Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: GMMV.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: GMMV.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: GMMV.F has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: GMMV.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Information is not available.

Information is not available.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: GMMV.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: GMMV.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of -55.7% each year


Next Steps

Dividend

What is G Medical Innovations Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.7%industryaverage1.0%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate GMMV.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate GMMV.F's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if GMMV.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GMMV.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GMMV.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of G Medical Innovations Holdings's salary, the management and board of directors tenure and is there insider trading?

2.2yrs

Average management tenure


CEO

Yacov Geva (69yo)

4.9yrs

Tenure

US$480,000

Compensation

Dr. Yacov Geva serves as the Chief Executive Officer, President and Executive Director of G Medical Innovations Holdings Limited since October 3, 2014. Dr. Geva was the Co-Founder of LifeWatch AG and serve ...


CEO Compensation Analysis

Information is not available.

Compensation vs Earnings: Insufficient data to compare Yacov's compensation with company performance.


Management Age and Tenure

2.2yrs

Average Tenure

58yo

Average Age

Experienced Management: GMMV.F's management team is considered experienced (2.2 years average tenure).


Board Age and Tenure

2.6yrs

Average Tenure

67yo

Average Age

Experienced Board: GMMV.F's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: GMMV.F insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$68,66218 Jul 19
Kenneth Melani
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares500,000
Max PriceUS$0.14
BuyUS$127,01603 Jun 19
Yacov Geva
EntityIndividual
Role
Chief Executive Officer
President
Shares742,168
Max PriceUS$0.17

Ownership Breakdown


Management Team

  • Yacov Geva (69yo)

    President

    • Tenure: 4.9yrs
    • Compensation: US$480.00k
  • Rafi Heumann (49yo)

    Chief Operating Officer

    • Tenure: 4.7yrs
    • Compensation: US$160.00k
  • Steven Wood

    Company Secretary

    • Tenure: 1.3yrs
  • Kobi Ben-Efraim (62yo)

    Chief Financial Officer

    • Tenure: 3.9yrs
    • Compensation: US$160.00k
  • Nir Geva (45yo)

    Chief Technology Officer

    • Tenure: 1.5yrs
    • Compensation: US$160.00k
  • Oded Shahar (58yo)

    Senior Vice President of Mergers & Acquisitions

    • Tenure: 2.2yrs
  • Uri Marom

    Executive Vice President of Operations of China

    • Tenure: 0.7yrs

Board Members

  • Yacov Geva (69yo)

    President

    • Tenure: 4.9yrs
    • Compensation: US$480.00k
  • Urs Wettstein (63yo)

    Non-Executive Director

    • Tenure: 2.6yrs
    • Compensation: US$40.00k
  • Shuki Gleitman (69yo)

    Non-Executive Director

    • Tenure: 2.6yrs
    • Compensation: US$40.00k
  • Ken Melani (65yo)

    Non-Executive Chairman

    • Tenure: 5.1yrs
    • Compensation: US$100.00k
  • Brendan de Kauwe (42yo)

    Non-Executive Director

    • Tenure: 2.6yrs
    • Compensation: US$40.00k
  • Zeev Rotstein (69yo)

    Non-Executive Director

    • Tenure: 0.5yrs

Company Information

G Medical Innovations Holdings Ltd's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: G Medical Innovations Holdings Ltd
  • Ticker: GMMV.F
  • Exchange: OTCPK
  • Founded: 2014
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$32.966m
  • Listing Market Cap: AU$22.615m
  • Shares outstanding: 406.98m
  • Website: https://gmedinnovations.com

Location

  • G Medical Innovations Holdings Ltd
  • Willow House
  • PO Box 10008
  • George Town
  • KY1-1001
  • Cayman Islands

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GMVASX (Australian Securities Exchange)YesOrdinary SharesAUAUDMay 2017
GMVCHIA (Chi-X Australia)YesOrdinary SharesAUAUDMay 2017
9GMDB (Deutsche Boerse AG)YesOrdinary SharesDEEURMay 2017
GMMV.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDMay 2017

Biography

G Medical Innovations Holdings Ltd operates as a mobile health and e-health company. It develops and markets clinical and consumer medical-grade health monitoring solutions. The company develops Medical Sm ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/08 00:30
End of Day Share Price2019/06/10 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.